NCT06297421

Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults

Efficacy and Safety of Fecal Microbiota Transplantation for the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) and Mental Health Comorbidity in Young Adults: A Randomized, Double-blind, Placebo Controlled Study

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 88 (estimated)
• Sponsor: Shenzhen Hospital of Southern Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 29 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Fecal Microbiota Transplantation compared with placebo in the treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) and Mental Health Comorbidity in Young Adults.

Conditions

• Irritable Bowel Syndrome With Diarrhea
• Fecal Microbiota Transplantation
• Mental Health Issue

Interventions

Type	Name	Description
PROCEDURE	Fecal Microbiota Transplantation	Oral Fecal Microbiota Transplantation Capsule
PROCEDURE	Placebo	Oral Placebo Capsule

Timeline

• Start date: 2024-09-01
• Primary completion: 2026-01-01
• Completion: 2026-06-01
• First posted: 2024-03-07
• Last updated: 2024-07-16

Locations

1 site across 1 country: China